West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
530 Herman O. West Drive, Exton, PA
State of incorporation
PA
Fiscal year end
December 31
Former names
WEST CO INC (to 2/11/1999)
Latest financial report
10-Q - Q3 2024 - Oct 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 270 % -26.5%
Quick Ratio 68.2 % -17.9%
Debt-to-equity 34 % +2.16%
Return On Assets 13.7 % -9.63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.4M shares -2.12%
Common Stock, Shares, Outstanding 72.5M shares -2.03%
Entity Public Float 28.2B USD +26.5%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 72.8M shares -2.02%
Weighted Average Number of Shares Outstanding, Diluted 73.4M shares -2.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 695M USD -2.96%
Revenue from Contract with Customer, Excluding Assessed Tax 2.88B USD -1.71%
Research and Development Expense 69M USD +4.7%
Operating Income (Loss) 571M USD -11.4%
Nonoperating Income (Expense) 17.6M USD +28.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 165M USD -12%
Income Tax Expense (Benefit) 105M USD -9.85%
Net Income (Loss) Attributable to Parent 500M USD -10.7%
Earnings Per Share, Basic 6.81 USD/shares -9.32%
Earnings Per Share, Diluted 6.74 USD/shares -9.16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 491M USD -45.4%
Accounts Receivable, after Allowance for Credit Loss, Current 524M USD +1%
Inventory, Net 401M USD -7.09%
Other Assets, Current 134M USD +9.28%
Assets, Current 1.55B USD -21.4%
Deferred Income Tax Assets, Net 37.6M USD +117%
Property, Plant and Equipment, Net 1.57B USD +19.8%
Operating Lease, Right-of-Use Asset 108M USD +11.6%
Intangible Assets, Net (Excluding Goodwill) 12.3M USD -21.7%
Goodwill 109M USD +1.87%
Other Assets, Noncurrent 69.3M USD +78.6%
Assets 3.68B USD -2.12%
Accounts Payable, Current 224M USD +2.05%
Liabilities, Current 517M USD -3.19%
Deferred Income Tax Liabilities, Net 9.4M USD -43%
Operating Lease, Liability, Noncurrent 82.3M USD -0.84%
Other Liabilities, Noncurrent 66.8M USD +21.2%
Liabilities 923M USD +4.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax -136M USD +38.9%
Retained Earnings (Accumulated Deficit) 3.86B USD +12.9%
Stockholders' Equity Attributable to Parent 2.75B USD -4.05%
Liabilities and Equity 3.68B USD -2.12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 118M USD -14.4%
Net Cash Provided by (Used in) Financing Activities -271M USD -282%
Net Cash Provided by (Used in) Investing Activities -90.6M USD -10.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -252M USD -3051%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 491M USD -45.4%
Deferred Tax Assets, Valuation Allowance 15.5M USD +16.5%
Operating Lease, Liability 102M USD +2.71%
Depreciation 34.7M USD +13%
Payments to Acquire Property, Plant, and Equipment 90.6M USD +10.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 586M USD -9.09%
Lessee, Operating Lease, Liability, to be Paid 116M USD +0.78%
Property, Plant and Equipment, Gross 2.99B USD +14.7%
Operating Lease, Liability, Current 19.9M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.2M USD +18.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.2M USD +21.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -8M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.2M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.5M USD +9.93%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD -2.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 38.8M USD +6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.1M USD +43.9%
Operating Lease, Payments 29.5M USD +74.6%
Additional Paid in Capital 23.3M USD -81%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 200K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 98.2M USD -24.9%
Share-based Payment Arrangement, Expense 15.8M USD -44.8%
Interest Expense 700K USD -75.9%